Investigación

Sarcomas e Histiocitosis

Buscador de publicaciones

Publicaciones

  • Rosé A, André N, Rozados VR, Mainetti LE, Márquez MM, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Mora J, García WG, Epelman S, Alasino C, Alonso D, Chantada G and Scharovsky OG.

    Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.

    ecancermedicalscience . 10: 672-672. Nº de citas: 10

    [doi:10.3332/ecancer.2016.672]

  • Mora J, Suñol M, Rodriguez E and de Torres C.

    Vascular tumors preceding Ewing sarcoma: clinico-pathological observations

    Sarcoma Research International . 2(3): 1021.

  • Pérez-Jaume S and Carrasco JL.

    A non-parametric approach to estimate the total deviation index for non-normal data

    STATISTICS IN MEDICINE . 34(25): 3318-3335. Nº de citas: 5

    [doi:10.1002/sim.6544]

  • Garzón M, García-Fructuoso G, Suñol M, Mora J and Cruz-Martínez O.

    Low-grade gliomas in children: single institutional experience in 198 cases

    CHILDS NERVOUS SYSTEM . 31(9): 1447-1459. Nº de citas: 8

    [doi:10.1007/s00381-015-2800-9]

  • Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.

    Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts

    PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de citas: 10

    [doi:10.1007/s11095-015-1671-9]

  • Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.

    The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

    Oncotarget . 6(22): 18875-18890. Nº de citas: 70

    [doi:10.18632/oncotarget.4303]

  • Mora J, Cruz-Martínez O, Lavarino C, Rios J, Vancells M, Parareda A, Salvador-Hernandez H, Suñol M, Carrasco-Torrents R, Guillen-Quesada A, Mañé S and de Torres C.

    Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)

    CLINICAL & TRANSLATIONAL ONCOLOGY . 17(7): 521-529. Nº de citas: 14

    [doi:10.1007/s12094-014-1273-8]

  • Puerta P, Guillen-Quesada A, Mora J, Suñol M and Ferrer E.

    Isolated skull metastasis of Ewing's Sarcoma in a child

    Austin Journal of Cancer and Clinical Research . 2(5): 1046.

  • Gomez-Gonzalez S, Castellano G, Mayol G, Suñol M, Queiros A, Bibikova M, Nazor KL, Loring JF, Lemos I, Rodríguez E, de Torres C, Mora J, Martín-Subero JI and Lavarino C.

    DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights

    EPIGENOMICS . 7(7): 1137-1153. Nº de citas: 40

    [doi:10.2217/epi.15.49]

  • Mora J, Modak S, Cheung NK, Meyers P, de Alava E, Kushner B, Magnan H, Tirado OM, Laquaglia M, Ladanyi M and Rosai J.

    Desmoplastic small round cell tumor 20 years after its discovery

    FUTURE ONCOLOGY . 11(7): 1071-1081. Nº de citas: 37

    [doi:10.2217/fon.15.32]